Costs & Coverage
Most insurance companies utilized by long-stay residents, including Medicare Part D and Medicaid plans, cover the cost of this testing for eligible members.
6.3 billion drugs are prescribed annually in the US.
PharMerica strives to continually elevate its clinical offerings to help clients improve their outcomes, ratings, and growth in an increasingly competitive market. PharMerica has partnered with AccessDx Laboratory, a nationwide provider of precision medicine solutions, to offer pharmacogenomic risk assessments and testing to help facilities and providers identify, monitor, and manage potential issues associated with resident medications. To learn more, contact your PharMerica account manager or email PharMerica@AccessDxLab.com.
